No profile data available.
Compass Pathways plc (CMPS) is a healthcare company in the brain and nerve treatment drugs industry, based in London, United Kingdom, with about 156 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$287.86 million. Its market capitalization was $1.66 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.
Compass Pathways reported $0 in revenue for fiscal year 2025.
$1.66 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Harmony Biosciences Holdings, Inc. (HRMY), Sarepta Therapeutics, Inc. (SRPT), Biohaven Ltd. (BHVN), Stoke Therapeutics, Inc. (STOK).